<?xml version="1.0" encoding="UTF-8"?>
<ref id="B57">
 <label>57.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Chen</surname>
    <given-names>WH</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Hotez</surname>
    <given-names>PJ</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Bottazzi</surname>
    <given-names>ME</given-names>
   </name>
  </person-group>
  <article-title>Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19</article-title>. 
  <source>Hum. Vaccin. Immunother.</source>
  <fpage>1</fpage>â€“
  <lpage>4</lpage> (
  <year>2020</year>).
 </mixed-citation>
</ref>
